Home Authors Posts by Kaden Gilbert

Kaden Gilbert

2023 POSTS 0 COMMENTS
The shares of Perion Network Ltd. (NASDAQ:PERI) has been pegged with a rating of Buy by Lake Street in its latest research note that was published on July 08, 2019. The Technology company has also assigned a $6 price target. Lake Street wasn’t the only research firm that published...
The shares of Rexford Industrial Realty Inc. (NYSE:REXR) has been pegged with a rating of Neutral by JP Morgan in its latest research note that was published on December 19, 2018. JP Morgan wasn’t the only research firm that published a report of Rexford Industrial Realty Inc., with other...
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 1 believe it has the potential for further growth, thus rating it as Hold while 0 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is...
The shares of Ocular Therapeutix Inc. (NASDAQ:OCUL) has been pegged with a rating of Buy by H.C. Wainwright in its latest research note that was published on May 21, 2019. The Healthcare company has also assigned a $9 price target. H.C. Wainwright wasn’t the only research firm that published...
The shares of Mersana Therapeutics Inc. (NASDAQ:MRSN) has been pegged with a rating of Buy by H.C. Wainwright in its latest research note that was published on January 21, 2020. The Healthcare company has also assigned a $12 price target. H.C. Wainwright wasn’t the only research firm that published...
The shares of Seabridge Gold Inc. (NYSE:SA) has been pegged with a rating of Buy by B. Riley FBR in its latest research note that was published on April 30, 2019. The Basic Materials company has also assigned a $22 price target. B. Riley FBR wasn’t the only research...
The shares of Fluent Inc. (NASDAQ:FLNT) has been pegged with a rating of Mkt Perform by Barrington Research in its latest research note that was published on November 12, 2019. Barrington Research wasn’t the only research firm that published a report of Fluent Inc., with other equities research analysts...
The shares of Albemarle Corporation (NYSE:ALB) has been pegged with a rating of Hold by Vertical Research in its latest research note that was published on February 21, 2020. Vertical Research wasn’t the only research firm that published a report of Albemarle Corporation, with other equities research analysts also...
The price of the stock the last time has raised by 131.61% from its 52-Week high price while it is -77.26% than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 45.46. The shares of the company dipped by -14.59%...
The shares of Moleculin Biotech Inc. (NASDAQ:MBRX) has been pegged with a rating of Buy by ROTH Capital in its latest research note that was published on December 20, 2017. The Healthcare company has also assigned a $8 price target. ROTH Capital wasn’t the only research firm that published...